Sign in

CIK 0001818794

  • Large accelerated filer

Dyne Therapeutics, Inc.

Sign in to watch
Ticker
DYN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
364883909
Phone
+1 781-786-8230
Business address
1560 TRAPELO ROAD, WALTHAM, MA, 02451
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Grant or award Chief Medical Officer acquired 50,000 shares (grant or award)
  5. 3 Insider Initial Statement of Ownership
  6. 4 Conversion 10% owner acquired 4,951,303 shares (conversion)
  7. 4 Open-market buy 10% owner bought 815,000 shares at $19.00 ($15,485,000)
  8. 4 Conversion Director acquired 53,625 shares (conversion)
  9. 4 Open-market buy 10% owner bought 700,000 shares at $19.00 ($13,300,000)
  10. 4 Conversion 10% owner acquired 6,131,079 shares (conversion)
  11. 4 Conversion 10% owner acquired 602,972 shares (conversion)
  12. 4 Conversion Director acquired 10,725 shares (conversion)
  13. 4 Conversion Director acquired 10,725 shares (conversion)
  14. 4 Conversion Director acquired 7,638,511 shares (conversion)
  15. 4 Conversion Director acquired 6,131,079 shares (conversion)
  16. 4 Conversion 10% owner acquired 1,608,785 shares (conversion)
  17. 4 Conversion 10% owner acquired 7,638,511 shares (conversion)
  18. 4 Open-market buy 10% owner bought 660,000 shares at $19.00 ($12,540,000)
  19. 4 Conversion Director acquired 4,951,303 shares (conversion)
  20. 4 Grant or award Chief Operating Officer acquired 35,904 shares (grant or award)

Page 17 of 19 · 365 filings